BackProvention Bio Overview

Provention Bio Intangible Assets

Track Provention Bio's intangible assets ($60M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Intangible Assets
$59.56M

Peer average / median

Loading

Provention Bio Intangible Assets History

Loading

Provention Bio vs. peers: Intangible Assets Comparison

Loading

Provention Bio Intangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Provention Bio (PRVB) FAQ

Provention Bio (PRVB) currently reports a intangible assets of $60M as of December 2022. In the prior-year period, the figure was $0. Use the charts on this page to explore Provention Bio's intangible assets history and peer comparisons.

Provention Bio's intangible assets changed from $0 to $60M (period ending December 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Provention Bio reported $60M in intangible assets as of December 2022. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current intangible assets of $60M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Provention Bio, and consider following PRVB for alerts when major investors trade the stock.

Provention Bio is classified in the Healthcare sector. On intangible assets, it currently shows $60M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing PRVB with unrelated industries.